T. Rowe Price Associates’s GE HealthCare GEHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152M | Sell |
2,055,454
-910,880
| -31% | -$67.5M | 0.02% | 489 |
|
|
2025
Q1 | $239M | Sell |
2,966,334
-3,198,337
| -52% | -$258M | 0.03% | 387 |
|
|
2024
Q4 | $482M | Sell |
6,164,671
-408,038
| -6% | -$31.9M | 0.06% | 274 |
|
|
2024
Q3 | $617M | Sell |
6,572,709
-761,448
| -10% | -$71.5M | 0.07% | 244 |
|
|
2024
Q2 | $571M | Sell |
7,334,157
-2,627,361
| -26% | -$205M | 0.07% | 247 |
|
|
2024
Q1 | $906M | Sell |
9,961,518
-2,132,389
| -18% | -$194M | 0.11% | 176 |
|
|
2023
Q4 | $935M | Sell |
12,093,907
-165,487
| -1% | -$12.8M | 0.13% | 162 |
|
|
2023
Q3 | $834M | Sell |
12,259,394
-3,517,555
| -22% | -$239M | 0.12% | 175 |
|
|
2023
Q2 | $1.28B | Sell |
15,776,949
-2,545,313
| -14% | -$207M | 0.18% | 114 |
|
|
2023
Q1 | $1.5B | Buy |
18,322,262
+11,962,261
| +188% | +$981M | 0.23% | 94 |
|
|
2022
Q4 | $371M | Buy |
+6,360,001
| New | +$371M | 0.06% | 280 |
|